al-Taha R - Search Results

1

Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas. A clinicopathologic study of 58 patients using mitotic count, MIB-1 staining, and DNA cytophotometry.

Jochum W, Schröder S, al-Taha R, August C, Gross AJ, Berger J, Padberg BC. Jochum W, et al. Among authors: al taha r. Cancer. 1996 Feb 1;77(3):514-21. doi: 10.1002/(SICI)1097-0142(19960201)77:3<514::AID-CNCR13>3.0.CO;2-7. Cancer. 1996. PMID: 8630959

2

Increased risk of brain metastases in patients with HER-2/neu-positive breast carcinoma.

Altaha R, Crowell E, Hobbs G, Higa G, Abraham J. Altaha R, et al. Cancer. 2005 Feb 1;103(3):442-3. doi: 10.1002/cncr.20813. Cancer. 2005. PMID: 15578684 Free article. No abstract available.

3

Paraneoplastic neurologic syndrome associated with occult breast cancer: a case report and review of literature.

Altaha R, Abraham J. Altaha R, et al. Breast J. 2003 Sep-Oct;9(5):417-9. doi: 10.1046/j.1524-4741.2003.09514.x. Breast J. 2003. PMID: 12968965 Review.

4

Breast and ovarian cancer genetics and prevention.

Altaha R, Reed E, Abraham J. Altaha R, et al. W V Med J. 2003 Sep-Oct;99(5):187-91. W V Med J. 2003. PMID: 14959510

5

Epothilones: a novel class of non-taxane microtubule-stabilizing agents.

Altaha R, Fojo T, Reed E, Abraham J. Altaha R, et al. Curr Pharm Des. 2002;8(19):1707-12. doi: 10.2174/1381612023394043. Curr Pharm Des. 2002. PMID: 12171542 Review.

6

Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients.

Vinjamuri M, Adumala RR, Altaha R, Hobbs GR, Crowell EB Jr. Vinjamuri M, et al. J Neurooncol. 2009 Jan;91(2):221-5. doi: 10.1007/s11060-008-9702-6. Epub 2008 Sep 24. J Neurooncol. 2009. PMID: 18813874 Clinical Trial.

7

5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.

Higa GM, Auber ML, Altaha R, Piktel D, Kurian S, Hobbs G, Landreth K. Higa GM, et al. J Oncol Pharm Pract. 2006 Dec;12(4):201-9. doi: 10.1177/1078155206072080. J Oncol Pharm Pract. 2006. PMID: 17156592 Clinical Trial.

8

Concordance between substance P levels and antiemetic guidelines.

Higa GM, Auber ML, Altaha R, Kurian S, Hobbs G. Higa GM, et al. J Support Oncol. 2009 Jul-Aug;7(4):138-42. J Support Oncol. 2009. PMID: 19731580

9

Epidermal growth factor receptor as a target for cancer therapy.

Altaha R, Abraham J. Altaha R, et al. Expert Rev Anticancer Ther. 2007 Jan;7(1):1-3. doi: 10.1586/14737140.7.1.1. Expert Rev Anticancer Ther. 2007. PMID: 17187514 No abstract available.

10

Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: report of two cases and review of literature.

Nagaiah G, Almubarak M, Khan M, Altaha R. Nagaiah G, et al. Cancer Invest. 2010 Dec;28(10):1048-53. doi: 10.3109/07357907.2010.483499. Epub 2010 Sep 27. Cancer Invest. 2010. PMID: 20873990 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters